Literature DB >> 1561973

Supraventricular tachycardia mechanisms and their age distribution in pediatric patients.

J K Ko1, B J Deal, J F Strasburger, D W Benson.   

Abstract

To better define the natural history of supraventricular tachycardia (SVT) in young patients, age distribution of SVT mechanisms was examined in 137 infants, children and adolescents. Patients with a history of cardiac surgery or neuromuscular diseases were excluded. An electrophysiologic study was performed in each patient: transesophageal (110 patients) or transvenous (14 patients) or both (13 patients). Mechanisms were classified as SVT using accessory atrioventricular (AV) connection (SVT using accessory connection, including orthodromic and antidromic reciprocating tachycardia), primary atrial tachycardia (including chaotic, automatic and reentrant atrial tachycardia), and tachycardia due to reentry within the AV node. SVT using accessory connection occurred in 100 of 137 patients (73%) and was the most prevalent mechanism. Primary atrial tachycardia and reentry within the AV node were present in 19 of 137 (14%) and 18 of 137 (13%) patients, respectively. Using a multinomial logit model, relative probabilities for tachycardia mechanisms for 5 age groups--prenatal, less than 1, 1 to 5, 6 to 10 and greater than 10 years--were determined. Primary atrial tachycardia (11 to 16%) and SVT using accessory connection (58 to 84%) appeared throughout infancy, childhood and adolescence. On the other hand, tachycardia due to reentry within the AV node (0 to 31%) rarely appeared before age 2 years. Mechanisms of SVT appear to have age-dependent distributions. SVT using accessory connection is the most common mechanism in young patients. We speculate that the propensity to tachycardia due to reentry within the AV node occurs during postnatal development.

Entities:  

Mesh:

Year:  1992        PMID: 1561973     DOI: 10.1016/0002-9149(92)90858-v

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  54 in total

Review 1.  Fetal cardiac arrhythmia detection and in utero therapy.

Authors:  Janette F Strasburger; Ronald T Wakai
Journal:  Nat Rev Cardiol       Date:  2010-05       Impact factor: 32.419

2.  Medications used to manage supraventricular tachycardia in the infant a North American survey.

Authors:  K K Wong; J E Potts; S P Etheridge; S Sanatani
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

3.  Low-energy radiofrequency catheter ablation as therapy for supraventricular tachycardia in a premature neonate.

Authors:  Denise P Kolditz; Nico A Blom; Regina Bökenkamp; Martin J Schalij
Journal:  Eur J Pediatr       Date:  2005-05-12       Impact factor: 3.183

4.  Cardiogenic shock in a neonate.

Authors:  Eulália Viveiros; Ana Cristina Aveiro; Edite Costa; José Luis Nunes
Journal:  BMJ Case Rep       Date:  2013-06-03

Review 5.  Safety issues in the treatment of paediatric supraventricular tachycardias.

Authors:  J P Pfammatter; U Bauersfeld
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

Review 6.  Management of Arrhythmias in Pediatric Emergency.

Authors:  Manojkumar Rohit; Ganesh Kasinadhuni
Journal:  Indian J Pediatr       Date:  2020-03-13       Impact factor: 1.967

Review 7.  Management of Supraventricular Tachycardia in Infants.

Authors:  Chalese Richardson; Eric S Silver
Journal:  Paediatr Drugs       Date:  2017-12       Impact factor: 3.022

8.  Coronary sinus morphology in pediatric patients with supraventricular tachycardia.

Authors:  Matthew B Ambrose; Jennifer N Avari Silva; Michael Rudokas; Tammy M Bowman; Joshua Murphy; George F Van Hare
Journal:  J Interv Card Electrophysiol       Date:  2018-02-03       Impact factor: 1.900

9.  Supraventricular tachycardia as a complication of severe diabetic ketoacidosis in an adolescent with new-onset type 1 diabetes.

Authors:  Bryan Padraig Finn; Brian Fraser; Susan M O'Connell
Journal:  BMJ Case Rep       Date:  2018-03-15

10.  Pediatric radiofrequency catheter ablation: results of initial 100 consecutive cases including congenital heart anomalies.

Authors:  Eun-Jung Bae; Ji-Eun Ban; Jung A Lee; Sun-Mi Jin; Chung-Il Noh; Jung-Yun Choi; Yong-Soo Yun
Journal:  J Korean Med Sci       Date:  2005-10       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.